GlassScriptPhysician profile
Richard W Pidutti
NPI 1215956016
$7,874.21
in general payments reported to CMS, 2019-2025
44 companies · $1,305 in 2025
The $1,305 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,042 · 2020: $528 · 2021: $775 · 2022: $1,508 · 2023: $1,200 · 2024: $1,516 · 2025: $1,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,021.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,470.35 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $935.42 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $777.92 | 2019-2025 | |
| Janssen Biotech, INC. | $629.36 | 2019-2025 | Erleada |
| Abbvie INC. | $472.42 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $388.49 | 2019-2025 | |
| Hollister Incorporated | $352.56 | 2021-2023 | Infyna Chic, Onli, Vapro |
| Tolmar, INC. | $305.70 | 2023-2025 | Eligard, Jatenzo |
| Boston Scientific Corporation | $272.81 | 2019-2025 | Ams 700, Axonics |
| Tolmar Pharmaceuticals, INC. | $264.87 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $189.04 | 2024-2025 | Adstiladrin |
| Urovant Sciences INC | $181.44 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $176.48 | 2020-2024 | Keytruda, Lynparza, Welireg |
| Kowa Pharmaceuticals America, INC. | $123.60 | 2022-2023 | Seglentis |
| C. R. Bard, INC. & Subsidiaries | $119.29 | 2022-2025 | Bard Urinary Drainage Bag, Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $119.28 | 2022-2024 | |
| Blue Earth Diagnostics | $101.76 | 2020-2022 | |
| Procept Biorobotics Corporation | $100.00 | 2024 | Aquabeam System |
| Axonics, INC. | $88.62 | 2024 | Axonics, Bulkamid |
| Coloplast Corp | $84.00 | 2023-2024 | Speedicath |
| Verity Pharmaceuticals INC. | $63.89 | 2025 | Trelstar, Tlando |
| Dentsply Ih INC. | $63.37 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $60.62 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Amgen INC. | $50.51 | 2019-2022 | |
| Myovant Sciences INC. | $50.39 | 2021-2022 | |
| Olympus America INC. | $40.73 | 2022-2025 | Itind System |
| Palette Life Sciences, INC. | $39.98 | 2023 | |
| Novartis Pharmaceuticals Corporation | $33.57 | 2025 | |
| Neotract INC. | $27.22 | 2019 | |
| Sandoz INC. | $23.72 | 2024 | Hyrimoz |
| Antares Pharma, INC. | $22.97 | 2023 | Tlando, Nocdurna, Xyosted |
| Smith+Nephew, INC. | $21.92 | 2023 | Grafix Pl |
| Dendreon Pharmaceuticals LLC | $20.86 | 2023 | Provenge |
| Teleflex LLC | $20.54 | 2023 | Urolift |
| Urogen Pharma, INC. | $20.40 | 2022 | |
| Immunitybio, INC. | $20.28 | 2025 | |
| Endo Pharmaceuticals INC. | $19.58 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.41 | 2021 | |
| Halozyme INC | $18.59 | 2023 | |
| Janssen Scientific Affairs, LLC | $18.40 | 2019 | |
| Kerecis Limited | $17.32 | 2022 | |
| 180 Medical, INC. | $17.20 | 2019 | |
| Travere Therapeutics, INC. | $15.93 | 2019 | |
| Merz Pharmaceuticals, LLC | $13.40 | 2024 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Pidutti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.